SIRNA AGAINST CBL-B AND OPTIONALLY IL-2 AND IL-12 FOR USE IN THE TREATMENT OF CANCER

• 收藏
• 分享

专利权人:

发明人:

Gunther Lametschwandtner,Hans Loibner,Manfred Schuster,Isabella Haslinger,Sandra Seidl

申请号：

US14801366

公开号：

US20150313931A1

申请日:

2015.07.16

申请国别(地区):

US

年份:

2015

代理人:

摘要：

The invention relates to a method for the immune activation of NK cells by the reduction or inhibition of the Cbl-b function in said cells. This stimulates the congenital immune system and thus permits the therapy of appropriate diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/